Pacific Capital Partners LTD Trans Medics Group, Inc. Transaction History

Pacific Capital Partners LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 May 08, 2025	BUY	$59.28 - $144.9 $711,360 - $1.74 Million	12,000 New	12,000 $748 Million
Q3 2024 May 08, 2025	BUY	$135.68 - $176.11 $1.33 Million - $1.72 Million	9,782 New	9,782 $1.54 Billion
Q2 2024 May 08, 2025	SELL	$72.62 - $150.62 $204,570 - $424,296	-2,817 Reduced 19.6%	11,556 $1.74 Million
Q1 2024 May 08, 2025	BUY	$70.86 - $89.93 $128,965 - $163,672	1,820 Added 14.5%	14,373 $1.06 Billion
Q4 2023 May 08, 2025	BUY	$36.74 - $81.08 $60,841 - $134,268	1,656 Added 15.2%	12,553 $991 Million

Q3 2023 May 08, 2025	BUY	$53.47 - $96.07 $582,662 - $1.05 Million	10,897 New	10,897 $597 Million

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $3.66B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Pacific Capital Partners LTD, based on Form 13F filings with the SEC.

Stay updated on Pacific Capital Partners LTD with notifications on news.